|
Unitedhealth Group Common
(UNH)
|
5.4 |
$143M |
|
271k |
530.18 |
|
Amgen Common
(AMGN)
|
5.0 |
$134M |
|
509k |
262.64 |
|
Gilead Sciences Common
(GILD)
|
4.9 |
$130M |
-6%
|
1.5M |
85.85 |
|
Johnson & Johnson Common
(JNJ)
|
4.3 |
$113M |
-18%
|
640k |
176.65 |
|
Eli Lilly and Company Common
(LLY)
|
4.0 |
$106M |
+20%
|
289k |
365.84 |
|
Vertex Pharmaceuticals Common
(VRTX)
|
3.6 |
$95M |
+5%
|
330k |
288.78 |
|
Regeneron Pharmaceuticals Common
(REGN)
|
3.3 |
$87M |
+10%
|
121k |
721.49 |
|
AbbVie Common
(ABBV)
|
2.9 |
$77M |
-9%
|
478k |
161.61 |
|
Abbott Laboratories Common
(ABT)
|
2.9 |
$76M |
-12%
|
693k |
109.79 |
|
Pfizer Common
(PFE)
|
2.8 |
$75M |
+28%
|
1.5M |
51.24 |
|
AstraZeneca Sponsored ADR
(AZN)
|
2.6 |
$69M |
-19%
|
1.0M |
67.80 |
|
Illumina Common
(ILMN)
|
2.4 |
$65M |
+8%
|
320k |
202.20 |
|
Merck & Co Common
(MRK)
|
2.3 |
$61M |
|
552k |
110.95 |
|
Cigna Corp. Common
(CI)
|
2.3 |
$61M |
-13%
|
183k |
331.34 |
Setup an alert
Hambrecht & Quist Capital Management will file the next quarterly 13-HR in about 2 months. Would you like to be notified?
|
|
Biogen Common
(BIIB)
|
2.0 |
$54M |
+34%
|
195k |
276.92 |
|
Thermo Fisher Scientific Common
(TMO)
|
1.9 |
$52M |
|
94k |
550.69 |
|
Bristol-Myers Squibb Company Common
(BMY)
|
1.9 |
$50M |
-21%
|
688k |
71.95 |
|
Moderna Common
(MRNA)
|
1.8 |
$48M |
-15%
|
265k |
179.62 |
|
Horizon Therapeutics Common
(HZNP)
|
1.8 |
$47M |
-43%
|
415k |
113.80 |
|
Stryker Corp. Common
(SYK)
|
1.5 |
$40M |
-15%
|
164k |
244.49 |
|
Humana Common
(HUM)
|
1.5 |
$40M |
-31%
|
78k |
512.19 |
|
Boston Scientific Corp. Common
(BSX)
|
1.3 |
$35M |
-4%
|
757k |
46.27 |
|
Alnylam Pharmaceuticals Common
(ALNY)
|
1.3 |
$34M |
|
143k |
237.65 |
|
Zimmer Biomet Holdings Common
(ZBH)
|
1.2 |
$33M |
|
259k |
127.50 |
|
United Therapeutics Corp. Common
(UTHR)
|
1.2 |
$32M |
|
115k |
278.09 |
|
argenx SE Sponsored ADR
(ARGX)
|
1.2 |
$32M |
+9%
|
84k |
378.83 |
|
Intuitive Surgical Common
(ISRG)
|
1.1 |
$30M |
+7%
|
113k |
265.35 |
|
Jazz Pharmaceuticals Shares
(JAZZ)
|
1.1 |
$29M |
|
183k |
159.31 |
|
Danaher Corp. Common
(DHR)
|
1.1 |
$28M |
-15%
|
106k |
265.42 |
|
IDEXX Laboratories Common
(IDXX)
|
1.0 |
$28M |
+25%
|
68k |
407.96 |
|
Medtronic Shares
(MDT)
|
1.0 |
$25M |
|
326k |
77.72 |
|
HCA Healthcare Common
(HCA)
|
1.0 |
$25M |
-15%
|
105k |
239.96 |
|
McKesson Corp. Common
(MCK)
|
0.9 |
$25M |
+97%
|
67k |
375.12 |
|
Dexcom Common
(DXCM)
|
0.9 |
$25M |
-11%
|
218k |
113.24 |
|
Molina Healthcare Common
(MOH)
|
0.9 |
$24M |
-38%
|
74k |
330.22 |
|
BioMarin Pharmaceutical Common
(BMRN)
|
0.9 |
$24M |
+52%
|
231k |
103.49 |
|
Zoetis Class A
(ZTS)
|
0.8 |
$20M |
|
137k |
146.55 |
|
Sarepta Therapeutics Common
(SRPT)
|
0.7 |
$18M |
-15%
|
141k |
129.58 |
|
Novo Nordisk A/S Sponsored ADR
(NVO)
|
0.7 |
$18M |
|
131k |
135.34 |
|
Lantheus Holdings Common
(LNTH)
|
0.7 |
$18M |
+49%
|
343k |
50.96 |
|
Charles River Laboratories International Common
(CRL)
|
0.6 |
$16M |
|
73k |
217.90 |
|
BioNTech SE Sponsored ADS
(BNTX)
|
0.6 |
$16M |
+9%
|
104k |
150.22 |
|
Ascendis Pharma A/S Sponsored ADR
(ASND)
|
0.6 |
$15M |
+82%
|
124k |
122.13 |
|
uniQure Shares
(QURE)
|
0.6 |
$15M |
+25%
|
652k |
22.67 |
|
Seagen Common
(SGEN)
|
0.5 |
$14M |
+110%
|
112k |
128.51 |
|
Neurocrine Biosciences Common
(NBIX)
|
0.5 |
$14M |
-32%
|
113k |
119.44 |
|
IQVIA Holdings Common
(IQV)
|
0.5 |
$13M |
-6%
|
63k |
204.89 |
|
Guardant Health Common
(GH)
|
0.5 |
$13M |
+36%
|
472k |
27.20 |
|
Edwards Lifesciences Corp. Common
(EW)
|
0.5 |
$13M |
|
171k |
74.61 |
|
ResMed Common
(RMD)
|
0.5 |
$13M |
|
61k |
208.13 |
|
Novartis Sponsored ADR
(NVS)
|
0.5 |
$12M |
|
136k |
90.72 |
|
SPDR S&P Biotech ETF S&P Biotech ETF
(XBI)
|
0.5 |
$12M |
|
148k |
83.00 |
|
Acadia Healthcare Company Common
(ACHC)
|
0.4 |
$12M |
|
141k |
82.32 |
|
Rallybio Corporation Common
(RLYB)
|
0.4 |
$11M |
|
1.7M |
6.57 |
|
Align Technology Common
(ALGN)
|
0.4 |
$11M |
+168%
|
51k |
210.90 |
|
Karuna Therapeutics Common
(KRTX)
|
0.4 |
$11M |
+126%
|
54k |
196.50 |
|
Laboratory Corporation of America Holdings Common
(LH)
|
0.4 |
$10M |
|
44k |
235.48 |
|
Avantor Common
(AVTR)
|
0.4 |
$9.7M |
NEW
|
460k |
21.09 |
|
Intra-Cellular Therapies Common
(ITCI)
|
0.3 |
$9.1M |
|
172k |
52.92 |
|
Travere Therapeutics Common
(TVTX)
|
0.3 |
$8.8M |
+68%
|
419k |
21.03 |
|
CVS Health Corp. Common
(CVS)
|
0.3 |
$8.7M |
-24%
|
94k |
93.19 |
|
Omega Healthcare Investors Common
(OHI)
|
0.3 |
$8.6M |
|
306k |
27.95 |
|
Alkermes Shares
(ALKS)
|
0.3 |
$8.1M |
|
310k |
26.13 |
|
BioCryst Pharmaceuticals Common
(BCRX)
|
0.3 |
$7.7M |
+92%
|
673k |
11.48 |
|
Denali Therapeutics Common
(DNLI)
|
0.3 |
$7.6M |
+22%
|
273k |
27.81 |
|
Allscripts Healthcare Solutions Common
(MDRX)
|
0.3 |
$7.6M |
|
429k |
17.64 |
|
Elevance Health Common
(ELV)
|
0.3 |
$7.5M |
|
15k |
512.97 |
|
HealthEquity Common
(HQY)
|
0.3 |
$6.8M |
|
110k |
61.64 |
|
LTC Properties Common
(LTC)
|
0.2 |
$6.5M |
|
182k |
35.53 |
|
Agilent Technologies Common
(A)
|
0.2 |
$6.5M |
|
43k |
149.65 |
|
VectivBio Holding Common
(VECT)
|
0.2 |
$6.4M |
-2%
|
738k |
8.61 |
|
Sabra Health Care REIT Common
(SBRA)
|
0.2 |
$6.3M |
|
511k |
12.43 |
|
Sanofi Sponsored ADR
(SNY)
|
0.2 |
$6.0M |
|
124k |
48.43 |
|
Catalent Common
(CTLT)
|
0.2 |
$5.7M |
NEW
|
126k |
45.01 |
|
Cerevel Therapeutics Holdings Common
(CERE)
|
0.2 |
$5.6M |
|
177k |
31.54 |
|
Intellia Therapeutics Common
(NTLA)
|
0.2 |
$5.4M |
|
154k |
34.89 |
|
Xencor Common
(XNCR)
|
0.2 |
$5.2M |
|
200k |
26.04 |
|
Smith & Nephew Sponsored ADR
(SNN)
|
0.2 |
$4.9M |
|
182k |
26.89 |
|
BeiGene Sponsored ADR
(BGNE)
|
0.2 |
$4.6M |
|
21k |
219.94 |
|
Medical Properties Trust Common
(MPW)
|
0.2 |
$4.6M |
|
412k |
11.14 |
|
Addus HomeCare Corp. Common
(ADUS)
|
0.2 |
$4.2M |
-49%
|
42k |
99.49 |
|
Prometheus Biosciences Common
(RXDX)
|
0.2 |
$4.2M |
+21%
|
38k |
110.00 |
|
Teva Pharmaceutical Industries Sponsored ADR
(TEVA)
|
0.2 |
$4.2M |
|
460k |
9.12 |
|
Arrowhead Pharmaceuticals Common
(ARWR)
|
0.2 |
$4.1M |
-35%
|
100k |
40.56 |
|
Healthpeak Properties Common
(PEAK)
|
0.1 |
$3.8M |
|
150k |
25.07 |
|
Caribou Biosciences Common
(CRBU)
|
0.1 |
$3.6M |
|
567k |
6.28 |
|
Kura Oncology Common
(KURA)
|
0.1 |
$3.5M |
NEW
|
283k |
12.41 |
|
Cytokinetics Common
(CYTK)
|
0.1 |
$3.4M |
|
75k |
45.82 |
|
Apellis Pharmaceuticals Common
(APLS)
|
0.1 |
$3.4M |
-75%
|
66k |
51.71 |
|
Amerisourcebergen Corp. Common
(ABC)
|
0.1 |
$3.4M |
NEW
|
20k |
165.71 |
|
Healthcare Realty Trust Common
(HR)
|
0.1 |
$3.4M |
|
175k |
19.27 |
|
Ionis Pharmaceuticals Common
(IONS)
|
0.1 |
$3.3M |
|
88k |
37.77 |
|
Xenon Pharmaceuticals Common
(XENE)
|
0.1 |
$3.3M |
+35%
|
84k |
39.43 |
|
Adaptive Biotechnologies Corp. Common
(ADPT)
|
0.1 |
$3.2M |
|
422k |
7.64 |
|
Ishares Biothechnology ETF Common
(IBB)
|
0.1 |
$3.2M |
|
25k |
131.29 |
|
MoonLake Immunotherapeutics Common
(MLTX)
|
0.1 |
$3.2M |
|
300k |
10.50 |
|
Ultragenyx Pharmaceutical Common
(RARE)
|
0.1 |
$3.1M |
|
67k |
46.33 |
|
Steris Shares
(STE)
|
0.1 |
$3.1M |
|
17k |
184.69 |
|
Ventas Common
(VTR)
|
0.1 |
$3.0M |
|
67k |
45.05 |
|
Syndax Pharmaceuticals Common
(SNDX)
|
0.1 |
$3.0M |
NEW
|
118k |
25.45 |
|
Mirati Therapeutics Common
(MRTX)
|
0.1 |
$3.0M |
-46%
|
66k |
45.31 |
|
Blueprint Medicines Corp. Common
(BPMC)
|
0.1 |
$3.0M |
NEW
|
68k |
43.81 |
|
Welltower Common
(WELL)
|
0.1 |
$2.7M |
|
42k |
65.55 |
|
Bicycle Therapeutics Sponsored ADS
(BCYC)
|
0.1 |
$2.6M |
|
89k |
29.60 |
|
Physicians Realty Trust Common
(DOC)
|
0.1 |
$2.4M |
|
169k |
14.47 |
|
IDEAYA Biosciences Common
(IDYA)
|
0.1 |
$2.4M |
|
133k |
18.17 |
|
Cardiovascular Systems Common
(CSII)
|
0.1 |
$2.4M |
|
175k |
13.62 |
|
G1 Therapeutics Common
(GTHX)
|
0.1 |
$2.3M |
|
424k |
5.43 |
|
CRISPR Therapeutics Namen AKT
(CRSP)
|
0.1 |
$2.2M |
|
55k |
40.65 |
|
R1 RCM Common
(RCM)
|
0.1 |
$2.2M |
|
202k |
10.95 |
|
Arcutis Biotherapeutics Common
(ARQT)
|
0.1 |
$2.2M |
|
149k |
14.80 |
|
Medpace Holdings Common
(MEDP)
|
0.1 |
$2.0M |
|
9.4k |
212.41 |
|
Natera Common
(NTRA)
|
0.1 |
$2.0M |
+130%
|
49k |
40.17 |
|
Option Care Health Common
(OPCH)
|
0.1 |
$2.0M |
|
65k |
30.09 |
|
Icon Shares
(ICLR)
|
0.1 |
$1.8M |
-10%
|
9.3k |
194.25 |
|
Assertio Holdings Common
(ASRT)
|
0.1 |
$1.8M |
|
411k |
4.30 |
|
Perrigo Company Shares
(PRGO)
|
0.1 |
$1.7M |
|
51k |
34.09 |
|
Edgewise Therapeutics Common
(EWTX)
|
0.1 |
$1.7M |
|
195k |
8.94 |
|
Global Medical REIT Common
(GMRE)
|
0.1 |
$1.7M |
|
175k |
9.48 |
|
Koninklijke Philips NY Reg Shares
(PHG)
|
0.1 |
$1.6M |
-33%
|
110k |
14.99 |
|
Takeda Pharmaceutical Company Sponsored ADS
(TAK)
|
0.1 |
$1.6M |
|
105k |
15.60 |
|
Ardelyx Common
(ARDX)
|
0.1 |
$1.5M |
|
539k |
2.85 |
|
Arvinas Common
(ARVN)
|
0.1 |
$1.5M |
-50%
|
43k |
34.21 |
|
GSK Sponsored ADR
(GSK)
|
0.1 |
$1.5M |
|
42k |
35.14 |
|
Merus Common
(MRUS)
|
0.1 |
$1.4M |
-45%
|
92k |
15.47 |
|
Galera Therapeutics Common
(GRTX)
|
0.1 |
$1.3M |
|
898k |
1.49 |
|
Protagonist Therapeutics Common
(PTGX)
|
0.1 |
$1.3M |
NEW
|
122k |
10.91 |
|
Zai Lab Adr
(ZLAB)
|
0.1 |
$1.3M |
|
43k |
30.70 |
|
Stevanato Group Societa' Per Azioni Ordinary Shares
(STVN)
|
0.0 |
$1.3M |
|
71k |
17.97 |
|
Morphic Holding Common
(MORF)
|
0.0 |
$1.2M |
|
45k |
26.75 |
|
Sutro Biopharma Common
(STRO)
|
0.0 |
$1.2M |
-10%
|
148k |
8.08 |
|
Mereo BioPharma Group Ads
(MREO)
|
0.0 |
$1.2M |
|
1.6M |
0.75 |
|
ACADIA Pharmaceuticals Common
(ACAD)
|
0.0 |
$1.1M |
|
72k |
15.92 |
|
Scholar Rock Holding Corp. Common
(SRRK)
|
0.0 |
$985k |
|
109k |
9.05 |
|
Pyxis Oncology Common
(PYXS)
|
0.0 |
$949k |
|
708k |
1.34 |
|
Crinetics Pharmaceuticals Common
(CRNX)
|
0.0 |
$839k |
NEW
|
46k |
18.30 |
|
ALX Oncology Holdings Common
(ALXO)
|
0.0 |
$746k |
|
66k |
11.27 |
|
Affimed Common
(AFMD)
|
0.0 |
$727k |
|
586k |
1.24 |
|
Pliant Therapeutics Common
(PLRX)
|
0.0 |
$681k |
NEW
|
35k |
19.33 |
|
I-Mab Sponsored ADS
(IMAB)
|
0.0 |
$680k |
|
163k |
4.18 |
|
Novavax Common
(NVAX)
|
0.0 |
$656k |
|
64k |
10.28 |
|
Intercept Pharmaceuticals Common
(ICPT)
|
0.0 |
$644k |
|
52k |
12.37 |
|
Beam Therapeutics Common
(BEAM)
|
0.0 |
$619k |
|
16k |
39.11 |
|
Universal Health Realty Income Trust Common
(UHT)
|
0.0 |
$537k |
|
11k |
47.73 |
|
Community Healthcare Trust Common
(CHCT)
|
0.0 |
$533k |
|
15k |
35.80 |
|
National Health Investors Common
(NHI)
|
0.0 |
$524k |
|
10k |
52.22 |
|
1Life Healthcare Common
(ONEM)
|
0.0 |
$523k |
|
31k |
16.71 |
|
Theseus Pharmaceuticals Common
(THRX)
|
0.0 |
$498k |
|
100k |
4.98 |
|
Biohaven Common
(BHVN)
|
0.0 |
$487k |
NEW
|
35k |
13.88 |
|
Repare Therapeutics Common
(RPTX)
|
0.0 |
$429k |
|
29k |
14.71 |
|
Fulcrum Therapeutics Common
(FULC)
|
0.0 |
$426k |
NEW
|
59k |
7.28 |
|
Community Health Systems Common
(CYH)
|
0.0 |
$382k |
|
88k |
4.32 |
|
Adicet Bio Common
(ACET)
|
0.0 |
$361k |
|
40k |
8.94 |
|
TScan Therapeutics Common
(TCRX)
|
0.0 |
$326k |
|
200k |
1.63 |
|
Codexis Common
(CDXS)
|
0.0 |
$322k |
|
69k |
4.66 |
|
MorphoSys Sponsored ADS
(MOR)
|
0.0 |
$293k |
|
82k |
3.58 |
|
Mallinckrodt Shares
(MNK)
|
0.0 |
$272k |
NEW
|
35k |
7.75 |
|
Precision BioSciences Common
(DTIL)
|
0.0 |
$267k |
|
225k |
1.19 |
|
Vaxcyte Common
(PCVX)
|
0.0 |
$240k |
NEW
|
5.0k |
47.95 |
|
Black Diamond Therapeutics Common
(BDTX)
|
0.0 |
$238k |
|
132k |
1.80 |
|
Diversified Healthcare Trust Common
(DHC)
|
0.0 |
$231k |
|
358k |
0.65 |
|
Harpoon Therapeutics Common
(HARP)
|
0.0 |
$189k |
|
260k |
0.73 |
|
Praxis Precision Medicines Common
(PRAX)
|
0.0 |
$179k |
|
75k |
2.38 |
|
Nkarta Common
(NKTX)
|
0.0 |
$174k |
|
29k |
5.99 |
|
Fusion Pharmaceuticals Common
(FUSN)
|
0.0 |
$137k |
-57%
|
43k |
3.15 |
|
ARCA biopharma Common
(ABIO)
|
0.0 |
$77k |
|
33k |
2.36 |
|
Spectrum Pharmaceuticals Common
(SPPI)
|
0.0 |
$42k |
|
115k |
0.37 |
|
VYNE Therapeutics Common
(VYNE)
|
0.0 |
$20k |
|
135k |
0.15 |
|
Corbus Pharmaceuticals Holdings Common
(CRBP)
|
0.0 |
$17k |
|
154k |
0.11 |
|
AlerisLife Common
(ALR)
|
0.0 |
$13k |
|
24k |
0.55 |
|
NexGel Common
(NXGL)
|
0.0 |
$5.3k |
|
4.2k |
1.25 |
|
Bellicum Pharmaceuticals Common
(BLCM)
|
0.0 |
$4.3k |
|
6.0k |
0.72 |